🚀 VC round data is live in beta, check it out!
Jiangsu Yuyue Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Jiangsu Yuyue Medical and similar public comparables like Canon Marketing Japan, Mirion, Novanta, Imeik Technology Development and more.
Jiangsu Yuyue Medical Overview
About Jiangsu Yuyue Medical
Jiangsu Yuyue Medical Equipment And Supply Co Ltd is engaged in providing household medical devices, medical clinical products, and related medical services, R&D, manufacturing and sales of medical device products, and providing related solutions. The company's products are mainly focused on respiratory oxygen production, diabetes care, infection control solutions, household electronic testing and in vitro diagnostics, first aid, and clinical and rehabilitation devices.
Founded
2007
HQ
Employees
6.3K
Website
Financials (LTM)
EV
$4B
Jiangsu Yuyue Medical Financials
Jiangsu Yuyue Medical reported last 12-month revenue of $1B and EBITDA of $259M.
In the same LTM period, Jiangsu Yuyue Medical generated $259M in EBITDA and $251M in net income.
Revenue (LTM)
Jiangsu Yuyue Medical P&L
In the most recent fiscal year, Jiangsu Yuyue Medical reported revenue of $1B and EBITDA of $323M.
Jiangsu Yuyue Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $556M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $259M | XXX | $323M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $251M | XXX | $265M | XXX | XXX | XXX |
| Net Margin | 20% | XXX | 24% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Jiangsu Yuyue Medical Stock Performance
Jiangsu Yuyue Medical has current market cap of $5B, and enterprise value of $4B.
Market Cap Evolution
Jiangsu Yuyue Medical's stock price is $4.81.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $5B | 0.0% | XXX | XXX | XXX | $0.26 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJiangsu Yuyue Medical Valuation Multiples
Jiangsu Yuyue Medical trades at 2.9x EV/Revenue multiple, and 14.4x EV/EBITDA.
EV / Revenue (LTM)
Jiangsu Yuyue Medical Financial Valuation Multiples
As of April 20, 2026, Jiangsu Yuyue Medical has market cap of $5B and EV of $4B.
Equity research analysts estimate Jiangsu Yuyue Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Jiangsu Yuyue Medical has a P/E ratio of 19.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 2.9x | XXX | 3.4x | XXX | XXX | XXX |
| EV/EBITDA | 14.4x | XXX | 11.5x | XXX | XXX | XXX |
| EV/EBIT | 15.0x | XXX | 14.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.7x | XXX | XXX | XXX |
| P/E | 19.2x | XXX | 18.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 15.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jiangsu Yuyue Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Jiangsu Yuyue Medical Margins & Growth Rates
Jiangsu Yuyue Medical's revenue in the last 12 month grew by 12%.
Jiangsu Yuyue Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Jiangsu Yuyue Medical's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Jiangsu Yuyue Medical's rule of X is 50% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Jiangsu Yuyue Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | (25%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 33% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 50% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 17% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Jiangsu Yuyue Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Jiangsu Yuyue Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Canon Marketing Japan | XXX | XXX | XXX | XXX | XXX | XXX |
| Mirion | XXX | XXX | XXX | XXX | XXX | XXX |
| Novanta | XXX | XXX | XXX | XXX | XXX | XXX |
| Imeik Technology Development | XXX | XXX | XXX | XXX | XXX | XXX |
| Envista Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jiangsu Yuyue Medical M&A Activity
Jiangsu Yuyue Medical acquired XXX companies to date.
Last acquisition by Jiangsu Yuyue Medical was on XXXXXXXX, XXXXX. Jiangsu Yuyue Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Jiangsu Yuyue Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJiangsu Yuyue Medical Investment Activity
Jiangsu Yuyue Medical invested in XXX companies to date.
Jiangsu Yuyue Medical made its latest investment on XXXXXXXX, XXXXX. Jiangsu Yuyue Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Jiangsu Yuyue Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jiangsu Yuyue Medical
| When was Jiangsu Yuyue Medical founded? | Jiangsu Yuyue Medical was founded in 2007. |
| Where is Jiangsu Yuyue Medical headquartered? | Jiangsu Yuyue Medical is headquartered in China. |
| How many employees does Jiangsu Yuyue Medical have? | As of today, Jiangsu Yuyue Medical has over 6K employees. |
| Is Jiangsu Yuyue Medical publicly listed? | Yes, Jiangsu Yuyue Medical is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical trades under 002223 ticker. |
| When did Jiangsu Yuyue Medical go public? | Jiangsu Yuyue Medical went public in 2008. |
| Who are competitors of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical main competitors are Canon Marketing Japan, Mirion, Novanta, Imeik Technology Development. |
| What is the current market cap of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical's current market cap is $5B. |
| What is the current revenue of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical's last 12 months revenue is $1B. |
| What is the current revenue growth of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Jiangsu Yuyue Medical? | Current revenue multiple of Jiangsu Yuyue Medical is 2.9x. |
| Is Jiangsu Yuyue Medical profitable? | Yes, Jiangsu Yuyue Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Jiangsu Yuyue Medical? | Jiangsu Yuyue Medical's last 12 months EBITDA is $259M. |
| What is Jiangsu Yuyue Medical's EBITDA margin? | Jiangsu Yuyue Medical's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Jiangsu Yuyue Medical? | Current EBITDA multiple of Jiangsu Yuyue Medical is 14.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.